A four-year, open-label, multi-center, randomized, two-arm study of Genotropin® in patients with idiopathic short stature: comparison of an individualized, target-driven treatment regimen to standard dosing of Genotropin® - analysis of two-year data.

D.R. Counts,Lawrence A. Silverman,Mitchell E. Geffner,Natasa Rajicic,Judith Hey-Hadavi,Paul S. Thornton,Michael P. Wajnrajch

A four-year, open-label, multi-center, randomized, two-arm study of Genotropin® in patients with idiopathic short stature: comparison of an individualized, target-driven treatment regimen to standard dosing of Genotropin® - analysis of two-year data.

2013

D.R. Counts
Lawrence A. Silverman
Mitchell E. Geffner
Natasa Rajicic
Judith Hey-Hadavi
Paul S. Thornton
Michael P. Wajnrajch

Background: Several models have been developed to predict growth response to growth hormone (GH) based on auxological and biochemical parameters for children with

Keywords:

Regimen
Genotropin
Internal medicine
Diabetes mellitus
Endocrinology
Idiopathic short stature
Short stature
Dosing
Pediatrics
Medicine
open label
growth hormone
treatment regimen
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations